Active	Status	Sponsor type	Region	Phase	Filter
4 Active 5 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beboso, Ronnie
NCT04967664: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery	Recruiting	3	408	Europe, US	Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system	Averitas Pharma, Inc.	Post Surgical Neuropathic Pain	10/24	05/25
NCT04209543 / 2019-001289-14: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)	Active, not recruiting	3	1570	Europe, Canada, US, RoW	Estetrol oral tablet, Placebo oral tablet, Progesterone oral tablet	Estetra, ICON Clinical Research	Vasomotor Symptoms, Menopausal Symptoms	02/24	02/24
ARGON-2, NCT04378010: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH	Terminated	2b	98	Europe, Canada, US, RoW	EDP-305 1.5 mg, EDP-305, EDP-305 2 mg, Placebo	Enanta Pharmaceuticals, Inc	Non-Alcoholic Steatohepatitis	10/21	11/21
NCT05725057: Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis	Recruiting	1/2	30	Europe	AX-158, Placebo	Artax Biopharma Inc	Psoriasis, Plaque Psoriasis	10/24	12/24